U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7381173811N-Acetylcysteine for Patients With COPD and ChronicBronchitisNot yet recruitingNo Results AvailableChronic Obstructive Pulmonary Disease|Chronic BronchitisDrug: N-acetylcysteine|Drug: Oral acetylcysteinehttps://ClinicalTrials.gov/show/NCT01599884
7381273812Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary DiseaseActive, not recruitingNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: theophylline|Other: placebohttps://ClinicalTrials.gov/show/NCT01599871
7381373813Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy VolunteersCompletedNo Results AvailableReflux OesophagitisDrug: YF476|Drug: Omeprazolehttps://ClinicalTrials.gov/show/NCT01599858
7381473814The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed WorkersNot yet recruitingNo Results AvailableInadequate or Impaired Respiratory Functionhttps://ClinicalTrials.gov/show/NCT01599845
7381573815Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney CancerActive, not recruitingNo Results AvailableClear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage IV Renal Cell CancerDrug: pazopanib hydrochloride|Other: laboratory biomarker analysis|Procedure: dynamic contrast-enhanced magnetic resonance imaging|Other: pharmacogenomic studieshttps://ClinicalTrials.gov/show/NCT01599832
7381673816BAX 855 Dose-Escalation Safety StudyCompletedNo Results AvailableHemophilia ABiological: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method|Biological: PEGylated Recombinant Factor VIIIhttps://ClinicalTrials.gov/show/NCT01599819
7381773817Compare Ceftazidime-Avibactam and Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)CompletedNo Results AvailablecUTI|Complicated Urinary Tract Infection|Acute PyelonephritisDrug: CAZ-AVI|Drug: Doripenem|Drug: Either switch to oral therapy : 500 mg of Ciprofloxacin (oral)|Drug: or switch to oral therapy : 800 mg/160 mg of sulfamethoxazole/trimethoprimhttps://ClinicalTrials.gov/show/NCT01599806
7381873818Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib on Bone Metastases in Patients With Castrate Resistant Prostate CancerActive, not recruitingNo Results AvailableBone Metastases|Castrate-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate CancerDrug: cabozantinib|Other: laboratory biomarker analysis|Procedure: magnetic resonance imaginghttps://ClinicalTrials.gov/show/NCT01599793
7381973819Language Development in Preterm ChildrenActive, not recruitingNo Results AvailableLanguage Developmenthttps://ClinicalTrials.gov/show/NCT01599780
7382073820Spaulding-Harvard Model System: Effects of Transcranial Direct Current Stimulation (tDCS) on Chronic Pain in Spinal Cord InjuryRecruitingNo Results AvailableSpinal Cord Injury|Chronic Pain|Neuropathic PainDevice: Transcranial direct current stimulation (tDCS)https://ClinicalTrials.gov/show/NCT01599767
7382173821Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk PatientsRecruitingNo Results AvailableClear Cell Renal CarcinomaDrug: Axitinib|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01599754
7382273822X-ray Dose Reduction Study for Endovascular Interventional RadiologyCompletedHas ResultsCardiovascular DiseaseRadiation: Low-dose DSA (83% reduction compared to normal dose) with novel X-ray imaging technology.|Radiation: Normal dose DSA with conventional X-ray imaging technologyhttps://ClinicalTrials.gov/show/NCT01599741
7382373823Effect of Urocortins in Patients With Heart FailureCompletedNo Results AvailableHeart Failure|EndotheliumDrug: Urocortin 2, Urocortin 3 and Substance Phttps://ClinicalTrials.gov/show/NCT01599728
7382473824Translating Unique Learning for Incontinence PreventionActive, not recruitingNo Results AvailableUrinary IncontinenceBehavioral: Instructional DVD|Behavioral: Bladder Health Classhttps://ClinicalTrials.gov/show/NCT01599715
7382573825Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel DiseaseCompletedNo Results AvailableInflammatory Bowel DiseaseDrug: Iron Isomaltoside 1000https://ClinicalTrials.gov/show/NCT01599702
7382673826Pilot and Feasibility Study of a Mirrors Intervention for Reducing Delirium in Older Cardiac Surgical PatientsCompletedNo Results AvailablePostoperative DeliriumOther: Mirrors Interventionhttps://ClinicalTrials.gov/show/NCT01599689
7382773827Citrulline, Exercise Training and Muscle Strength in the ElderlyCompletedNo Results AvailableElderly PatientsDietary Supplement: Citrulline|Dietary Supplement: Non essential amino acidhttps://ClinicalTrials.gov/show/NCT01599676
7382873828Pain Management of Intensive Care Unit PatientsActive, not recruitingNo Results AvailablePainOther: Pain management algorithmhttps://ClinicalTrials.gov/show/NCT01599663
7382973829Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein OcclusionActive, not recruitingNo Results AvailableBranch Retinal Vein OcclusionDrug: Ranibizumab|Procedure: Laserhttps://ClinicalTrials.gov/show/NCT01599650
7383073830Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine TreatmentCompletedHas ResultsChronic Idiopathic UrticariaDrug: IGE025|Drug: placebohttps://ClinicalTrials.gov/show/NCT01599637
7380173801Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and ScalpCompletedNo Results AvailableActinic KeratosisDrug: Ingenol mebutate gel, 0.015%|Drug: Vehicle gelhttps://ClinicalTrials.gov/show/NCT01600014
7380273802A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)CompletedNo Results AvailableChronic Idiopathic ConstipationDrug: KWA-0711|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01600001
7380373803Study to Compare Milk Protein Isolate (MPI) With Caseinate in Terms of Protein UtilizationCompletedNo Results AvailableEnteral FeedsDietary Supplement: Caseinate|Dietary Supplement: Milk Protein Isolatehttps://ClinicalTrials.gov/show/NCT01599988
7380473804A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIVRecruitingNo Results AvailableHIV DementiaDrug: Long acting methylphenidate|Drug: Long acting methylphenidate|Drug: Matched placebohttps://ClinicalTrials.gov/show/NCT01599975
7380573805Influence of Cincalcet on Cognitive Functions in Healthy Human SubjectsCompletedNo Results AvailableMemory FunctionsDrug: Cinacalcet|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01599962
7380673806A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib TherapyActive, not recruitingNo Results AvailableMantle Cell LymphomaDrug: Ibrutinibhttps://ClinicalTrials.gov/show/NCT01599949
7380773807Open Label Clinical Trial of Alacramyn® in Pediatric Patients With Scorpion Sting EnvenomationCompletedNo Results AvailableScorpion Sting EnvenomationBiological: Antivenin Centruroides (scorpion) equine immune F(ab')2https://ClinicalTrials.gov/show/NCT01599936
7380873808Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting EnvenomationCompletedNo Results AvailableScorpion Sting EnvenomationBiological: Antivenin Centruroides (scorpion) equine immune F(ab')2https://ClinicalTrials.gov/show/NCT01599923
7380973809Scribes in the Emergency DepartmentNot yet recruitingNo Results AvailableScribes in the Emergency DepartmentOther: Scribeshttps://ClinicalTrials.gov/show/NCT01599910
7381073810Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult VolunteersCompletedNo Results AvailablePulmonary TuberculosisBiological: ID93 + GLA-SE|Biological: ID93 alonehttps://ClinicalTrials.gov/show/NCT01599897

* Görseller ve İçerik tekif hakkına sahip olabilir